P-383 A 16-gene signature reflecting tumor microenvironment predicts the risk of multiple myeloma patients treated by bortezomib-based therapiesGrazia Gargano, Sabino Ciavarella, Susanna Anita Pappagallo et al.|Clinical Lymphoma Myeloma & Leukemia|2023Cited by 0
Cutting‐Edge Technologies to Decode Tumor Microenvironment in Multiple MyelomaDoriana Gramegna, S. Ciavarella, Maria Carmela Vegliante et al.|Hematological Oncology|2026Cited by 0